BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gusev E, Sarapultsev A, Solomatina L, Chereshnev V. SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19. Int J Mol Sci 2022;23:1716. [PMID: 35163638 DOI: 10.3390/ijms23031716] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Matsuzaka Y, Yashiro R. Extracellular Vesicle-Based SARS-CoV-2 Vaccine. Vaccines 2023;11:539. [DOI: 10.3390/vaccines11030539] [Reference Citation Analysis]
2 Mukherjee AG, Wanjari UR, Gopalakrishnan AV, Kannampuzha S, Murali R, Namachivayam A, Ganesan R, Renu K, Dey A, Vellingiri B, Prabakaran DS. Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity. Vaccines 2023;11:510. [DOI: 10.3390/vaccines11030510] [Reference Citation Analysis]
3 Tuculeanu G, Barbu EC, Lazar M, Chitu-Tisu CE, Moisa E, Negoita SI, Ion DA. Coagulation Disorders in Sepsis and COVID-19-Two Sides of the Same Coin? A Review of Inflammation-Coagulation Crosstalk in Bacterial Sepsis and COVID-19. J Clin Med 2023;12. [PMID: 36675530 DOI: 10.3390/jcm12020601] [Reference Citation Analysis]
4 Milota T, Smetanova J, Bartunkova J. Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies. Pathogens 2023;12. [PMID: 36678457 DOI: 10.3390/pathogens12010109] [Reference Citation Analysis]
5 Fateev IV, Schöfer TV, Chepur SV, Ivchenko EV, Minnullin TI, Shubina AA, Stepanov AV. Dynamics of the content of immunoglobulin G to severe acute respiratory syndrome-2 in convalescents who have had a new coronavirus infection. Bulletin of the Russian Military Medical Academy 2023;24:659-666. [DOI: 10.17816/brmma108612] [Reference Citation Analysis]
6 Wallis RS, O'Garra A, Sher A, Wack A. Host-directed immunotherapy of viral and bacterial infections: past, present and future. Nat Rev Immunol 2023;23:121-33. [PMID: 35672482 DOI: 10.1038/s41577-022-00734-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
7 Kapten K, Orczyk K, Smolewska E. Immunity in SARS-CoV-2 Infection: Clarity or Mystery? A Broader Perspective in the Third Year of a Worldwide Pandemic. Arch Immunol Ther Exp (Warsz) 2023;71:7. [PMID: 36810662 DOI: 10.1007/s00005-023-00673-0] [Reference Citation Analysis]
8 Arishi NA, Althomali NM, Dighriri IM, Alharthi MS, Alqurashi GB, Musharraf RA, Albuhayri AH, Almalki MK, Alnami SA, Mashraqi ZO. An Overview of Fluvoxamine and its Use in SARS-CoV-2 Treatment. Cureus 2023;15:e34158. [PMID: 36843775 DOI: 10.7759/cureus.34158] [Reference Citation Analysis]
9 Strong MJ. SARS-CoV-2, aging, and Post-COVID-19 neurodegeneration. J Neurochem 2022. [PMID: 36458986 DOI: 10.1111/jnc.15736] [Reference Citation Analysis]
10 Reis HC, Turk V. COVID-DSNet: A novel deep convolutional neural network for detection of coronavirus (SARS-CoV-2) cases from CT and Chest X-Ray images. Artif Intell Med 2022;134:102427. [PMID: 36462906 DOI: 10.1016/j.artmed.2022.102427] [Reference Citation Analysis]
11 Greenbaum D, Gurwitz D, Joly Y. Editorial: COVID-19 pandemics: Ethical, legal and social issues. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1021865] [Reference Citation Analysis]
12 Maranduca MA, Vamesu CG, Tanase DM, Clim A, Drochioi IC, Pinzariu AC, Filip N, Dima N, Tudorancea I, Serban DN, Serban IL. The RAAS Axis and SARS-CoV-2: From Oral to Systemic Manifestations. Medicina (Kaunas) 2022;58. [PMID: 36556919 DOI: 10.3390/medicina58121717] [Reference Citation Analysis]
13 Gusev E. Molecular Mechanisms of Pathogenesis, Prevention, and Therapy of COVID-19: Summarizing the Results of 2021. Int J Mol Sci 2022;23. [PMID: 36430684 DOI: 10.3390/ijms232214210] [Reference Citation Analysis]
14 Agusi ER, Allendorf V, Eze EA, Asala O, Shittu I, Dietze K, Busch F, Globig A, Meseko CA. SARS-CoV-2 at the Human-Animal Interface: Implication for Global Public Health from an African Perspective. Viruses 2022;14. [PMID: 36366571 DOI: 10.3390/v14112473] [Reference Citation Analysis]
15 Elnawasany S. Complementary and Alternative Medicine in COVID-19 Infection, an Old Weapon Against a New Enemy. Medicinal Plants [Working Title] 2022. [DOI: 10.5772/intechopen.106866] [Reference Citation Analysis]
16 Kritsky IS, Zurochka VA, Hu D, Sarapultsev AP. Dynamics of changes in the number of SARS-CoV-2 seropositive patients over two years of the COVID-19 pandemic. Russian Journal of Immunology 2022;25:219-226. [DOI: 10.46235/1028-7221-1153-doc] [Reference Citation Analysis]
17 Cordeiro JFC, Fernandes TM, Toro DM, da Silva-neto PV, Pimentel VE, Pérez MM, de Carvalho JCS, Fraga-silva TFC, Oliveira CNS, Argolo JGM, Degiovani AM, Ostini FM, Puginna EF, da Silva JS, Santos IKFM, Bonato VLD, Cardoso CRB, Dias-baruffi M, Faccioli LH, Donadi EA, Sorgi CA, Fernandes APM; on behalf of the IMMUNOCOVID Study Group. The Severity of COVID-19 Affects the Plasma Soluble Levels of the Immune Checkpoint HLA-G Molecule. IJMS 2022;23:9736. [DOI: 10.3390/ijms23179736] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Amormino C, Tedeschi V, Paldino G, Arcieri S, Fiorillo MT, Paiardini A, Tuosto L, Kunkl M. SARS-CoV-2 Spike Does Not Possess Intrinsic Superantigen-like Inflammatory Activity. Cells 2022;11:2526. [DOI: 10.3390/cells11162526] [Reference Citation Analysis]
19 Weber S, Gerbes AL. COVID-19 and liver injury: hypoalbuminaemia and γGT should be observed at hospital admission. Gut 2022:gutjnl-2022-328214. [PMID: 35896361 DOI: 10.1136/gutjnl-2022-328214] [Reference Citation Analysis]
20 Li JP, Wu KH, Chao WR, Lee YJ, Yang SF, Chao YH. Immunomodulation of Mesenchymal Stem Cells in Acute Lung Injury: From Preclinical Animal Models to Treatment of Severe COVID-19. Int J Mol Sci 2022;23:8196. [PMID: 35897770 DOI: 10.3390/ijms23158196] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Salgüero Fernández S, Gabriel Medina P, Almería Lafuente A, Ballesteros Vizoso MA, Zamora Trillo A, Casals Mercadal G, Solé Enrech G, Lalana Garcés M, Guerra Ruiz AR, Ortiz Pastor O, Morales Ruiz M. Impact of SARS-CoV-2 infection on liver disease. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 2022;3:126-133. [DOI: 10.1515/almed-2022-0037] [Reference Citation Analysis]
22 Salgüero Fernández S, Gabriel Medina P, Almería Lafuente A, Ballesteros Vizoso MA, Zamora Trillo A, Casals Mercadal G, Solé Enrech G, Lalana Garcés M, Guerra Ruiz AR, Ortiz Pastor O, Morales Ruiz M. Infección por SARS-CoV-2 y su impacto en la enfermedad hepática. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 2022;3:134-141. [DOI: 10.1515/almed-2022-0010] [Reference Citation Analysis]
23 Karonova TL, Golovatyuk KA, Kudryavtsev IV, Chernikova AT, Mikhaylova AA, Aquino AD, Lagutina DI, Zaikova EK, Kalinina OV, Golovkin AS, Grant WB, Shlyakhto EV. Effect of Cholecalciferol Supplementation on the Clinical Features and Inflammatory Markers in Hospitalized COVID-19 Patients: A Randomized, Open-Label, Single-Center Study. Nutrients 2022;14. [PMID: 35807783 DOI: 10.3390/nu14132602] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
24 Yang S, Tong Y, Chen L, Yu W. Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19. Mol Biomed 2022;3:15. [PMID: 35593963 DOI: 10.1186/s43556-022-00077-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Pérez-gómez HR, Morfín-otero R, González-díaz E, Esparza-ahumada S, León-garnica G, Rodríguez-noriega E. The Multifaceted Manifestations of Multisystem Inflammatory Syndrome during the SARS-CoV-2 Pandemic. Pathogens 2022;11:556. [DOI: 10.3390/pathogens11050556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Gusev E, Zhuravleva Y. Inflammation: A New Look at an Old Problem. Int J Mol Sci 2022;23:4596. [PMID: 35562986 DOI: 10.3390/ijms23094596] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
27 Montaño LM, Sommer B, Gomez-verjan JC, Morales-paoli GS, Ramírez-salinas GL, Solís-chagoyán H, Sanchez-florentino ZA, Calixto E, Pérez-figueroa GE, Carter R, Jaimez-melgoza R, Romero-martínez BS, Flores-soto E. Theophylline: Old Drug in a New Light, Application in COVID-19 through Computational Studies. IJMS 2022;23:4167. [DOI: 10.3390/ijms23084167] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
28 Mahdi M, Hermán L, Réthelyi JM, Bálint BL. Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19. Int J Mol Sci 2022;23:3812. [PMID: 35409171 DOI: 10.3390/ijms23073812] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Saceleanu V, Moreanu MS, Covache-Busuioc RA, Mohan AG, Ciurea AV. SARS-COV-2 - the pandemic of the XXI century, clinical manifestations - neurological implications. J Med Life 2022;15:319-27. [PMID: 35450003 DOI: 10.25122/jml-2020-0151] [Reference Citation Analysis]